description
celgene is a global biopharmaceutical company
leading the way in
medical
innovation
to help
patient
live longer better
life
our
purpose
a
a company
is
to discover and develop therapy that will
change the course of human
health
we value
our passion for patient
quest for
innovation spirit of independence and love
of
challenge
with a presence in
more than 70 country
-
and growing
-
we look for talented people to grow our
business
advance our
science and contribute to our unique
culture
translational development
at celgene
a
role
of translational development
at celgene is
to provide
disease
specific
patient
selection
strategy
insight into
target
engagement and downstream phenotypic effect to guide and support
early
phase
development
program and late clinical
development
program
in
solid tumor including but not limited to gbm lung and pancreatic cancer
development of
deeper understanding of the
biology pathophysiology oncogenic microenvironment and immunological influencers in these
disease
state
to empower
existing and future
celgene
asset
translational development
is a central
theme
of many
pipeline and acquired
asset
at celgene
the position
holder will be expected to develop
a large
matrix
of internal and external stakeholder
across
relevant
disease and drug moas at the moment
the
drug
asset
span io epigenetics and protein homeostasis but
since we have a highly
active
process
of
external
innovation and partnership
the incumbent
must
demonstrate the ability
and willingness to pick up
new
area of
basic
and applied
science
a required
position description
leads
translational
disease
team
with deep
disease
drug
development and business
knowledge in
solid tumor
leads and oversees
execution of
strategy
on
all
component of translational development
approach
in
disease area
including but not limited to various
aspect of patient
selection
strategy
in
solid tumor and translational research
liaises with key
celgene
research and early development thematic center of excellence
area
including protein homeostasis immune-oncology bio-therapeutics and epigenetics and companion diagnostics
group
to help
formulate and execute on
new
hypothesis
driving
new
clinical biomarker assay for
unmet need
segment
disease
strategy for
new
target and development
candidate
and ensure
seamless
transition of patient
selection
strategy
beyond
phase
1
liaises with late clinical
development
program
to support late clinical
r and
d and mast project
supports
regulatory
and communication
need of late phase compound and
approved
drug
for the
disease area
identifies
need
gap and translational
question and applies knowledge
across all
disease
program and asset
in
celgene
portfolio and
combination
with external
asset
serves a translational
representative
on
disease
strategy
team and interface with
commercial
clinical
project
leadership and regulatory
team to define
patient
segment of unmet need
based on
rapidly evolving
clinical
program and commercial
landscape
overall
manager and
leader
of disease
focused
scientific
team
who
delivers
on
research lab
project
celgene
and iit clinical trial
project and oversight of td scientist
in the
disease area
to enable
decision making
for patient stratification identification and response
criterion
leads
small and
large
collaboration with academia and industry
partner to identify biobanks clinical trial and existing
database
to collate multi-parameter genomic and clinical
datasets
to mine
for
novel biomarkers of unmet need
patient
in conjunction with
computational biologist data scientist and statistician
interfaces with common
function
including
lab
head
to coordinate
laboratory
project
including
combination and resistance mechanism
collection and maintenance of biobank sample for
assay
discovery and validation
across
disease area
and
with
scientific
writer to address
regulatory
response
key
activity
will also
include
working closely with clinical
investigator
identifying opportunity for translational medicine
project
delivering
high quality
presentation and acting a
an
internal
disease
expert
li-cb1
qualifications
md and
phd
with significant immuno oncology and
solid tumor experience
qualifications
md and
phd in
with significant immune oncology and
solid tumor experience
exposure to
working
within
or interfacing with clinical
team
deep
disease and drug
development
knowledge
expertise in the integration of preclinical research and clinical
drug
development
ability to lead
basic
research
program
a well a
development and execution of clinical correlative science
strategy
management
experience with the ability to
set
priority
direct
project and implement
complex
strategy and
work on
cross-functional team
highly
effective
teamwork and interpersonal skill and
the ability to work
across
numerous
scientific
discipline
able to communicate
in both
written and verbal
format
complex
and detailed
information
in a manner
that enhances
understanding and ensures that
the recipient will be able to apply
the
information
presented
celgene is committed to equal opportunity
in the term and condition of employment
for all
employee and job
applicant
without regard to race color religion sex sexual orientation
age
gender identity or
gender expression national origin disability or veteran status
celgene complies with
all
applicable national
state and local law governing nondiscrimination in
employment
a well a
employment eligibility verification requirement of the immigration and nationality act
all
applicant
must have
authorization to work
for celgene in the us